How far is the functional cure of chronic hepatitis B from complete cure?
Journal Title: Journal of Clinical Hepatology - Year 2025, Vol 41, Issue 1
Abstract
Functional cure is currently the ideal treatment endpoint for chronic hepatitis B (CHB) in China and globally. HBsAg seroclearance and HBV DNA that cannot be detected in peripheral blood for more than 24 weeks marks the regression of hepatitis B virus (HBV) infection. However, there is still a lack of systematic description of the characteristics of intrahepatic HBV markers after HBsAg seroclearance. This article elaborates on the issues including the latest definition of functional cure, the characteristics of intrahepatic virological markers after HBsAg seroclearance, the significance of ultrasensitive serum HBsAg detection, and antiviral therapy for CHB patients with a low level of HBsAg, so as to improve the understanding of functional cure among clinicians.
Authors and Affiliations
Na GAO, Zhiliang GAO
Clinical efficacy of liver venous deprivation versus portal vein embolization in treatment of liver cancer with insufficient residual liver volume: A Meta-analysis
[Objective] To systematically evaluate the efficacy and prognosis of liver venous deprivation (LVD) versus portal vein embolization (PVE) in the treatment of hepatic malignancies with insufficient residual liver volu...
Risk prediction models for pancreatic fistula after pancreaticoduodenectomy: A systematic review and a Meta-analysis
[Objective] To systematically review the risk prediction models for postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD), and to provide a reference for the clinical screening and application o...
Influencing factors for meropenem-related liver injury and their predictive value
[Objective] To analyze the factors influencing meropenem-related liver injury (MRLI) and to explore their clinical predictive value. [Methods] A retrospective case-control study was conducted, and the Chinese Hospital...
The role of endoplasmic reticulum stress in non-alcoholic fatty liver disease and related targeted therapies
Non-alcoholic fatty liver disease (NAFLD) is a series of diseases characterized by hepatic steatosis and is also a metabolism-associated disease and an important factor for liver fibrosis, liver cirrhosis, and hepato...
Effect of pegylated interferon-α-2b therapy on cytotoxicity of virus-specific CD8+ T cells in HBeAg-negative patients with chronic hepatitis B virus infection
[Objective] To investigate the change in the activity of hepatitis B virus (HBV)-specific CD8+ T cells after pegylated interferon-α-2b (PEG-IFN-α-2b) therapy in HBeAg-negative patients with chronic HBV infection. [Me...